{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:54:33Z","timestamp":1791140073589,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.anaerobe.2004.04.003","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T01:37:42Z","timestamp":1091151462000},"page":"205-211","source":"Crossref","is-referenced-by-count":22,"title":["In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora"],"prefix":"10.1016","volume":"10","author":[{"given":"Sydney M","family":"Finegold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahera St","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann W","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calida M","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Molitoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2004.04.003_BIB1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.37.6.1364","article-title":"In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms","volume":"37","author":"Collins","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.anaerobe.2004.04.003_BIB2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB3","unstructured":"Staphylococcus aureus resistant to vancomycin\u2014United States. MMWR 2002;51(26): 565\u20137."},{"issue":"7","key":"10.1016\/j.anaerobe.2004.04.003_BIB4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1542\/pir.24-7-249","article-title":"The misuse of vancomycin","volume":"24","author":"Skae","year":"2003","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB5","doi-asserted-by":"crossref","unstructured":"Derlot E, Courvalin P. Mechanisms and implications of glycopeptide resistance in enterococci. Am J Med 1991;91:82S\u20135S.","DOI":"10.1016\/0002-9343(91)90348-2"},{"issue":"Suppl 4","key":"10.1016\/j.anaerobe.2004.04.003_BIB6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1469-0691.2001.00059.x","article-title":"Limitations of presently available glycopeptides in the treatment of gram-positive infection","volume":"7","author":"Ziglam","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/48.2.283","article-title":"In vitro activity of LY333328 (oritavancin) against gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci","volume":"48","author":"Noviello","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.anaerobe.2004.04.003_BIB8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/med.1014","article-title":"Vancomycin, teicoplanin, and ramoplanin","volume":"21","author":"Boger","year":"2001","journal-title":"Med Res Rev"},{"issue":"1","key":"10.1016\/j.anaerobe.2004.04.003_BIB9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.47.1.337-341.2003","article-title":"In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates","volume":"47","author":"Goldstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB10","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1021\/ja011080p","article-title":"A new structure for the substrate-binding antibiotic ramoplanin","volume":"123","author":"Lo","year":"2001","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/j.anaerobe.2004.04.003_BIB11","first-page":"385","article-title":"Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics","volume":"XVI","author":"Reynolds","year":"1990","journal-title":"Drugs Exp Clin Res"},{"issue":"7","key":"10.1016\/j.anaerobe.2004.04.003_BIB12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.34.3.413","article-title":"Inhibition of peptidoglycan biosynthesis by ramoplanin","volume":"34","author":"Somner","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB13","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1021\/ja000182x","article-title":"A new mechanism of action proposed for ramoplanin","volume":"122","author":"Lo","year":"2000","journal-title":"J Am Chem Soc"},{"issue":"10","key":"10.1016\/j.anaerobe.2004.04.003_BIB14","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/AAC.36.10.2342","article-title":"Bactericidal activity of ramoplanin against antibiotic-resistant enterococci","volume":"36","author":"Johnson","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB15","first-page":"56","article-title":"In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria","volume":"31","author":"Hassan","year":"1990","journal-title":"Singapore Med J"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jac\/25.2.217","article-title":"In-vitro studies of ramoplanin (MDL 62, 198)","volume":"25","author":"O\u2019Hare","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.anaerobe.2004.04.003_BIB17","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1128\/AAC.47.7.2334-2338.2003","article-title":"In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria","volume":"47","author":"Citron","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB18","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1086\/322687","article-title":"Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin","volume":"33","author":"Wong","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.anaerobe.2004.04.003_BIB19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/JCM.40.4.1160-1163.2002","article-title":"Molecular characterization of vancomycin-resistant enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin","volume":"40","author":"Baden","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB20","series-title":"Human intestinal microflora in health and disease","first-page":"355","author":"Finegold","year":"1983"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB21","unstructured":"USD DI. Drug information for the health care professional. vol. 1, March 1998, Sulfonamides, p. 2682; Trimethoprim, p. 2899."},{"issue":"2","key":"10.1016\/j.anaerobe.2004.04.003_BIB22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0022172400024025","article-title":"Oral dose and faecal concentration of antibiotics during antibiotic decontamination in mice and in a patient","volume":"73","author":"van der Waaij","year":"1974","journal-title":"J Hyg (Camb)"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB23","series-title":"Wadsworth-KTL anaerobic bacteriology manual","author":"Jousimies-Somer","year":"2002"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB24","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/JCM.41.4.1363-1369.2003","article-title":"16S ribosomal DNA sequence-based analysis of clinically significant gram positive anaerobic cocci","volume":"41","author":"Song","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.anaerobe.2004.04.003_BIB25","unstructured":"NCCLS. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. 5th ed. M11-A5. Wayne, PA: National Committee for Clinical Laboratory Standards; 2001."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996404000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996404000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T04:54:04Z","timestamp":1549342444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996404000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S1075996404000307"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2004.04.003","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}